Related Experiment Video
Updated: Jul 18, 2026
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
Nicholas Calvert1, David Wood1
1Department of Orthopaedic Surgery Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia.
Clinical Case Reports
|April 12, 2017
Abstract:
Chondroblastoma is a rare, benign bone tumor that represents 1-2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab.
